Attenuated vaccine against rabbit myxomatosis
The vaccine is intended for the prevention of rabbit myxomatosis in a safe zone, as well as in threatened and dysfunctional farms.
The vaccine provides the formation of an immune response in rabbits to myxomatosis 5-9 days after a single application of 12 months.
It is forbidden to vaccinate clinically sick and/or weakened animals.
In safe farms, animals are vaccinated once starting from 30-45 days of age. Animals in dysfunctional and threatened farms are vaccinated at 30-45 days of age with revaccination after 3 months.
Revaccination of animals is carried out annually.
The vaccine is administered intramuscularly in the back of the thigh or subcutaneously in a volume of 1 cm3 in compliance with the rules of asepsis and antiseptics.
Before use, the vaccine is dissolved in distilled water for injection at the rate of 1 cm3 of water per 1 commercial dose of the vaccine.